Articles tagged "Living donor"

2021 American Transplant Congress
Understanding Transplant Decision Making Concerns for African, Caribbean and Black Canadian Patients with End-Stage Kidney Disease
N. Singh¹, A. Wasim¹, W. Hajjar¹, K. Mohan¹, N. El-Dassouki¹, H. Habbal¹, L. Angarso¹, A. Dychiao¹, S. Macanovic¹, A. D. Waterman², I. Mucsi¹
¹University Health Network, Toronto, ON, Canada, ²David Geffen School of Medicine, UCLA, Los Angeles, CA
*Purpose: Compared to White Canadians, African, Caribbean and Black (ACB) Canadians with end stage kidney disease (ESKD) are less likely to receive a living donor…
2021 American Transplant Congress
Greater Social Vulnerability is Associated with Self-advocacy in the Living Donor Navigator Program
A. Carter, A. C. Kale, R. D. Reed, B. A. Shelton, H. Qu, M. C. McLeod, B. J. Orandi, R. M. Cannon, D. Anderson, P. MacLennan, V. Kumar, M. Hanaway, J. E. Locke
University of Alabama at Birmingham Hospital, Birmingham, AL
*Purpose: The Living Donor Navigator (LDN) program helps transplant candidates identify live donors by pairing them with an advocate - a friend or family member…
2021 American Transplant Congress
Living Donor Total Robotic Renal Transplantation: Early Single Center Experience
M. E. Tobon Lascano, S. Koganti, M. E. Akoad, M. Anastopoulos, C. J. Simon, B. A. Bouthot, E. D. Walshe, Y. L. Cheah
Transplant, Lahey Clinic, Burlington, MA
*Purpose: To establish the feasibility and evaluate the results and outcomes of a newly established totally robotic kidney transplant program.*Methods: Retrospective review of a single…
2021 American Transplant Congress
Long-term Outcomes of Donation After Cardiac Death and Living Donor Liver Transplant for Primary Sclerosing Cholangitis: An Analysis of UNOS Registry from 2002-2020
T. Kitajima, S. Nagai, T. Ivanics, T. Shamaa, K. Collins, M. Rizzari, A. Yoshida, M. Abouljoud, D. Moonka
Transplant and Hepatobiliary Surgery, Henry Ford Hospital, Detroit, MI
*Purpose: Use of donation after circulatory death (DCD) grafts is a reported risk factor for worse outcomes after liver transplant (LT) for primary sclerosing cholangitis…
2021 American Transplant Congress
High and Low Frequency Domino Liver Transplantation Centers Demonstrate Similar Outcomes
J. Panichella, H. Resweber, H. Curtis, K. Nguyen, A. Di Carlo, S. Karhadkar
Temple University School of Medicine, Philadelphia, PA
*Purpose: For patients with transthyretin (TTR) Amyloidosis, the only disease modifying treatment is an orthotopic liver transplant. However, because of the nature of this disease,…
2021 American Transplant Congress
Understanding Early Transplant Preparation: CKD 3-5 Patients’ Transplant Knowledge and Actions at Kaiser Permanente Southern California
R. Pines¹, S. H. Kawakita², G. H. Kim³, O. Ranasinghe⁴, B. Mittman⁵, B. Dub⁵, H. Wilhalme³, A. D. Waterman³
¹Santa Barbara Cottage Hospital, Santa Barbara, CA, ²Terasaki Institute, Los Angeles, CA, ³UCLA David Geffen School of Medicine, Los Angeles, CA, ⁴Outbreak Management Branch, Los Angeles County Department of Public Health, Los Angeles, CA, ⁵Research and Evaluation, Kaiser Permanente, Pasadena, CA
*Purpose: While consensus exists on the need to educate patients earlier about transplant, delays in education persist, leaving patients insufficient time to make optimal renal…
2021 American Transplant Congress
Single Center Experience in Ex Vivo Hilar Renal Artery Aneurysm Repair and Autotransplantation
A. Chang¹, K. Cederquist¹, P. Abt¹, G. Wang², B. Jackson², A. Naji¹
¹Transplant Surgery, University of Pennsylvania, Philadelphia, PA, ²Vascular Surgery, University of Pennsylvania, Philadelphia, PA
*Purpose: In this study, we review our centers experience with complex renal artery aneurysms using our preferred technique of open nephrectomy, ex vivo repair, and…
2021 American Transplant Congress
Comparison of Outcomes of Living Donor Liver Transplantation for Biliary Atresia Patients with and without Kasai Portoenterostomy
T. Kanmaz¹, O. Andacoglu¹, Y. Yankol², C. Karatas¹, N. Mecit¹, K. Acarli³, M. Kalayoglu¹
¹Koc University, Istanbul, Turkey, ²University of Wisconsin, Madison, WI, ³Memorial Hospital, Istanbul, Turkey
*Purpose: We evaluated 10 year outcomes and the potential predictors of outcomes after living donor liver transplant (LT) for biliary atresia (BA) patients with and…
2021 American Transplant Congress
Single Cell Analysis of Living Donor Kidneys Reveals Sex-based Diversity in Proximal Tubulargene Expression
C. M. McEvoy¹, J. M. Szusz², S. Clotet-Freixas¹, J. An², S. MacParland², G. Bader³, S. Q. Crome², A. Konvalinka¹
¹Ajmera Transplant Centre, Toronto General Hospital Research Institute, Toronto, ON, Canada, ²Immunology and Molecular Genetics, University of Toronto, Toronto General Hospital Research Institute, Toronto, ON, Canada, ³Donnolly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, ON, Canada
*Purpose: Males with chronic kidney disease (CKD) experience a more rapid decline in kidney function and progression to end-stage kidney disease than females. In vitro…
2021 American Transplant Congress
Creatinine Reduction Ratio at 2 Postoperative Day as a Predicting Factor of Long-Term Outcomes After Living Donor Kidney Transplantation
Y. Kinoshita, T. Shinzato, T. Shimizu, D. Iwami
Division of Renal Surgery and Transplantation, Department of Urology, Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan
*Purpose: Creatinine reduction ratio from 1 to 2 postoperative days (CRR2) under 30% has been defined as a slow graft function (SGF) and used to…